Profil
Derzeit bekleidet Sren Tulstrup die Position des President & Chief Executive Officer bei Hansa Biopharma AB. Herr Tulstrup ist außerdem Senior Vice President für Shire Human Genetic Therapies, Inc. Zuvor war Herr Tulstrup Chief Executive Officer für Vifor Pharma AG und Chief Executive Officer der Vifor Pharma Management AG (eine Tochtergesellschaft der Vifor Pharma AG), Vice President-Global Human Health bei Merck & Co. und Managing Director-Denmark bei Merck Sharp & Dohme Ltd. (eine Tochtergesellschaft von Merck & Co., Inc.), stellvertretender Regional Manager bei der Novartis AG und Principal bei Sandoz, Inc. (eine Tochtergesellschaft der Novartis AG), Principal bei Abbott Laboratories, President & Chief Executive Officer für Roche Innovation Center Copenhagen An und Senior Vice President für Shire Pharmaceuticals, Inc. Er erwarb einen Abschluss an der Copenhagen Business School und einen Abschluss an der Northwestern University.
Aktuelle Nachrichten zu Søren Tulstrup
Aktive Positionen von Søren Tulstrup
| Unternehmen | Position | Beginn |
|---|---|---|
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Corporate Officer/Principal | 26.09.2012 |
Ehemalige bekannte Positionen von Søren Tulstrup
| Unternehmen | Position | Ende |
|---|---|---|
| HANSA BIOPHARMA AB | Vorstandsvorsitzender | 24.04.2025 |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Vorstandsvorsitzender | 24.05.2016 |
| VIFOR PHARMA | Vorstandsvorsitzender | 01.01.2016 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2014 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Vorstandsvorsitzender | 01.01.2012 |
Ausbildung von Søren Tulstrup
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
















